References
- Wilkaitis J, Mulvihill T, Nasrallah H: Classic antipsychotic medications. In: Schatzberg A, Nemeroff C eds. American Psychiatric Association Textbook of Psychopharmacology, 3rd edition. Washington, DC: APA 2004:425–441
- López-Muñoz F, Alamo C, Shen W.W, Clervoy P, Rubio G, Cuenca E: History of the discovery and clinical introduction of chlorpromazine. Annals of Clinical Psychiatry 17(3)
- Kirkby KC: Social context and health consequences of the anti-psychotics introduction. Annals of Clinical Psychiatry 17(3)
- Granger B, Albu S: The haloperidol story. Annals of Clinical Psychiatry 17(3)
- Aparasu RR, Bhatara VS, Gupta S: U.S. national trends in the use of antipsychotics during office visits. Annals of Clinical Psychiatry 1998–2002; 17(3)
- Awad AG, Voruganti LN: New antipsychotics, compliance, quality of life, and subjective tolerability-are patients better off? Can J Psychiatry 2004; 49:297–302
- Miller AL, Hall CS, Buchanan RW, Buckley PF, Chiles JA, Conley RR, Crismon ML, Ereshefsky L, Essock SM, Finnerty M, Marder SR, Miller del D, McEvoy JP, Rush AJ, Saeed SA, Schooler NR, Shon SP, Stroup S, Tarin-Godoy B: The Texas Medication Algorithm Project antipsychotic algorithm for schizo-phrenia: 2003 update. J Clin Psychiatry 2004; 65:500–508
- Fountoulakis KN, Nimatoudis I, Iacovides A, Kaprinis G: Off-label indications for atypical antipsychotics: A systematic review. Ann Gen Hosp Psychiatry 2004; 3:4–13
- Alexopoulos G, Streim J, Carpenter D, Docherty J: The expert consensus panel for using antipsychotic agents in older patients—Introduction: methods, commentary, and summary. J Clin Psychi-atry 2004; 65\(suppl 2):1–105
- Lehman A, Kreyenbuhl J, Buchanan R, Dickerson F, Dixon L, Goldberg R, Green-Paden L, Tenhula W, Boerescu D, Tek C, Sandson N, Steinwachs D: The schizophrenia outcomes research team (PORT): Updated treatment recommendations 2003. Schizo-phrenia Bull 2004; 30:193–217
- Fleischhacker WW: New developments in the pharmacology of schizophrenia. J Neural Transm Suppl 2003; 64:105–117
- Kane JM, Malhotra A: The future of pharmacotherapy for schizo-phrenia. World Psychiatr 2003; 2:81–86
- Coyle if: The demise of old certitudes and the birth of novel opportunities in neuropsychopharmacology. Curr Opin Pharmacol 2004; 4:1–3